Thyrocare Tech Ltd
NSE: THYROCARE · Healthcare Service Provider · sector
₹470.65NSE close 2026-10-26
Key numbers
Market cap₹7,491 cr
Price₹470.65
52w high / low₹662 / ₹343
P/E42.6xSector median 22.9x
P/B12.8xSector median 2.0x
Book value₹36.8
Dividend yield1.99%Sector median 0.55%
ROE31.1%Sector median 5.4%
ROCE39.7%Sector median 6.8%
OPM31.4%Sector median 15.9%
Debt / equity0.00xSector median 0.07x
EV/EBITDA26.4xSector median 17.2x
Interest cover68.9x
Current ratio3.39x
Sales growth 3y+16.3%Sector median +13.5%
Profit growth 3y+36.2%Sector median +26.9%
PEG1.18x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹220 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 68.9x in the last 12 months.
- No promoter shares are pledged.
- Promoter holding fell by 20.04 percentage points in a year, to 51.02% (2026-09-30).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 9% of net profit in the last 12 months.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹470.65 on 2026-10-26: -28.9% from the 52-week high, +37.4% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,591.90 · low ₹360.00
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 177 | 166 | 187 | 193 | 217 | 196 | 224 | 240 |
| EBITDA | 48 | 42 | 58 | 58 | 71 | 52 | 75 | 77 |
| OPM % | 27.2% | 25.2% | 30.8% | 29.9% | 33.0% | 26.4% | 33.5% | 32.2% |
| Other income | 3 | 4 | 5 | 5 | 3 | 5 | 4 | 4 |
| Net profit | 27 | 19 | 22 | 39 | 48 | 29 | 47 | 52 |
| EPS (₹) | 1.66 | 1.19 | 1.39 | 2.45 | 3.02 | 1.82 | 2.99 | 3.23 |
| Revenue YoY | +22.1% | +17.8% | +19.7% | +24.3% | ||||
| Profit YoY | +79.9% | +51.8% | +117.1% | +34.1% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 589 | 527 | 572 | 687 | 829 | 876 |
| EBITDA | 235 | 120 | 137 | 190 | 256 | 275 |
| Net profit | 176 | 64 | 71 | 92 | 163 | 176 |
| EPS (₹) | 11.10 | 4.05 | 4.47 | 5.71 | 10.27 | 11.06 |
| Revenue growth | -10.6% | +8.6% | +20.2% | +20.6% | +21.1% | |
| Profit growth | -63.4% | +9.7% | +29.3% | +78.2% | +65.7% | |
| Dividend / share (₹) | 15.00 | 15.00 | 18.00 | 18.00 | 28.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +16.3% | +10.9% | +21.1% |
| Net profit | +36.2% | +7.6% | +65.7% |
| EPS | +36.3% | +7.6% | – |
| Share price | – | +23.3% (2y) | +8.9% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 534 | 527 | 547 | 586 |
| Borrowings | – | 0 | 22 | 0 | 0 |
| Cash & equivalents | – | 151 | 177 | 192 | 220 |
| Total assets | – | 633 | 644 | 693 | 747 |
| Fixed assets | – | 157 | 168 | 149 | 206 |
| Capital work in progress | – | 2 | 3 | 14 | 3 |
| Investments | – | 6 | 0 | 0 | 0 |
| Receivables | – | 85 | 43 | 73 | 74 |
| Inventory | – | 28 | 48 | 47 | 48 |
| Payables | – | 25 | 40 | 76 | 65 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 267 | 129 | 168 | 191 | 213 |
| Cash from investing | -120 | -39 | -91 | -53 | -23 |
| Cash from financing | -147 | -86 | -85 | -130 | -170 |
| Capex | 38 | 44 | 62 | 45 | 21 |
| Free cash flow | 229 | 86 | 106 | 146 | 192 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 12.1% | 13.4% | 16.7% | 27.8% |
| ROCE % | – | 16.8% | 18.2% | 27.4% | 36.6% |
| Debtor days | – | 59 | 28 | 39 | 33 |
| Inventory days | – | 62 | 104 | 89 | 81 |
| Payable days | – | 57 | 88 | 146 | 109 |
| Cash conversion cycle (days) | – | 64 | 44 | -18 | 5 |
| Working capital days | – | 136 | 120 | 115 | 116 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 51.02% |
| FIIs | 9.37% |
| DIIs | 25.92% |
| of which Mutual funds | 22.91% |
| of which Insurance | 1.91% |
| Public (non-institutions) | 13.70% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 71.06% | 71.06% | 71.06% | 60.93% | 60.93% | 60.92% | 60.92% | 51.02% |
| Promoter group | % |
|---|---|
| API Holdings Limited | 51.02% |
| Docon Technologies Private Limited | 0.00% |
| Public holders above 1% | % |
|---|---|
| HSBC Mutual Fund - HSBC Aggressive Hybrid Fund | 6.79% |
| Nippon Life India Trustee Ltd-a/c Nippon India Pharma Fund | 5.66% |
| ICICI Prudential Mutual Fund - ICICI Prudential Active Momentum Fund | 3.72% |
| Aditya Birla SUN Life Mutual Fund - Aditya Birla SUN Life Business Cycle Fund | 3.51% |
| Kotak Mahindra Life Insurance Company Ltd. | 1.57% |
75,186 shareholders. Pledged: 0.00% of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Diagnostic Testing Services | ₹772 cr | 93.2% | ₹198 cr | 25.6% |
| Imaging Services | ₹53 cr | 6.4% | ₹1 cr | 1.3% |
| Others | ₹3 cr | 0.4% | ₹2 cr | 74.5% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-06-23 | Dividend | Dividend - Rs 7 Per Share |
| 2025-11-28 | Bonus | Bonus 2:1 |
| 2025-10-24 | Dividend | Interim Dividend - Rs 7 Per Share |
| 2025-07-25 | Dividend | Dividend - Rs 21 Per Share |
| 2024-08-16 | Dividend | Dividend - Rs 18 Per Share |
| 2023-04-20 | Dividend | Interim Dividend - Rs 18 Per Share |
| 2022-07-25 | Other | Annual General Meeting |
| 2022-05-11 | Dividend | Interim Dividend - Rs 15 Per Share |
| 2021-06-17 | Dividend | Annual General Meeting/Dividend - Rs 15 Per Share |
| 2020-11-12 | Dividend | Interim Dividend - Rs 10 Per Share |
| 2019-11-21 | Dividend | Interim Dividend - Rs 5 Per Share |
| 2019-08-14 | Dividend | Dividend - Rs 20 Per Share |
| 2018-08-02 | Dividend | Annual General Meeting/Dividend- Rs 5 Per Share |
| 2018-02-15 | Dividend | Interim Dividend Rs 5/- Per Share |
| 2017-08-03 | Dividend | Annual General Meeting/Dividend - Rs 5/- Per Share |
| 2017-02-08 | Dividend | Interim Dividend Rs 5/- Per Share (Purpose Revised) |
| 2016-09-01 | Dividend | Annual General Meeting/Dividend - Rs 2.50 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Human Health and Social work activities: Activities of independent Diagnostics / Pathological Laboratories
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | THYROCARE |
| BSE code | 539871 |
| ISIN | INE594H01019 |
| Face value | ₹10.0 |
| Incorporated | 2000-01-28 |
| Website | www.thyrocare.com |
| Plants (India / abroad) | 40 / 1 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.